MacuLogix locks in $38.7 mln Series D

Pennsylvania-based MacuLogix, a medical device company in the optometry and ophthalmology industry, has secured $38.7 million in Series D round of financing. Vivo Capital led the round with participation from return backers Fisk Ventures, Roche Venture Fund, Berwind Private Equity and Life Sciences Greenhouse of Central Pennsylvania.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!